PACS
PACS Group, Inc.
SERVICES-SKILLED NURSING CARE FACILITIES
PACS Group (PACS) Stock: Buy, Sell, or Hold?
$49.10
+0.33 (+0.68%)
â˛
5d:
+5.18%
30d:
+10.84%
90d:
+7.98%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 03, 2026
0d
Protect PACS Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (55%)
Quality Score
38/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$44.43 â $49.11
Position: SLIGHTLY HIGH
Forward P/E & Valuation
17.5x
FAIR
vs 16.7x historical avg
Wall Street Target
$61.33
+24.9% upside
Options IV & Volume
25th pct IV
HIGH volume confirmation
Support / Resistance
$45.39 / $51.68
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: PACS is fairly priced but lacks strong directional signals. At 1.7% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 9, 2026 at $49.04 · last confirmed Nov 10, 2026
Strength: 4.8/10
Get Alerted When PACS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$64.00
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$39.74
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PACS is currently trading at $49.10, which is considered slightly high relative to its 30-day fair value range of $44.43 to $49.11. The stock's valuation (Forward PE: 17.5) is in line with its historical norms (16.7). At these levels, the market is pricing in 1.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PACS is in a uptrend. Immediate support is located at $45.39, while resistance sits at $51.68.
Market Sentiment: PACS scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $61.33 (+24.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PACS is in a uptrend. Immediate support is located at $45.39, while resistance sits at $51.68.
Market Sentiment: PACS scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $61.33 (+24.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$44.43 -
$49.11
Company Quality Score
38/100
(SELL)
Options IV Signal
25th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
54.6%
Trading Range & Key Levels
30-Day Trading Range
$44.43 -
$49.11
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$4.34
(8.8%)
Support Level
$45.39
Resistance Level
$51.68
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding PACS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Options cheap (IV 25th percentile)
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.9% below Wall St target ($61.33)
- NEUTRAL: Market pricing in 1.7% annual earnings growth - fairly valued
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
17.50
Wall Street Target
$61.33
(+24.9%)
Revenue Growth (YoY)
11.5%
Earnings Growth (YoY)
15.6%
Profit Margin
4.9%
Valuation Premium vs History
+1.7% premium
PE vs Historical
17.5 vs 16.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.7%
(market-implied from PE analysis)
1-Year Target
$49.93
(+2%)
2-Year Target
$50.78
(+3%)
3-Year Target
$51.65
(+5%)
3-Yr Target (if PE normalizes)
(PE: 18â17)
PE COMPRESSION
$49.29
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 8.9%)
$71.96
(+47%)
Base:
(SPY PE: 17.5, Growth: 8.9%)
$63.41
(+29%)
Bear:
(PE: 14.9, Growth: 8.9%)
$53.90
(+10%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 28.19 | Current EPS (TTM): $1.73
Bull Case
$87.00
(+77%)
Analyst growth 62.2%, PE expands to 31.0
Base Case
$79.09
(+61%)
Market implied 62.2%, PE stable at 28.2
Bear Case
$33.16
(-33%)
Severe decline -20.0%, PE contracts to 24.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share PACS Analysis
Share this live PACS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PACS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
The latest article discusses three REITs, including $PACS Group, that collect rent from doctors' offices, labs, nursing homes, and senior housing facilities. A $50,000 investment in each REIT would yield approximately $8,510 annually.
Key Retail Themes:
REITs
Healthcare Real Estate
High Yield Dividends
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 6:20 AM ET
Data refreshes hourly during market hours. Next update: 7:20 AM
Data refreshes hourly during market hours. Next update: 7:20 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
23 analysts |
$306 | 47 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 39 SELL |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 34 SELL |
|
CON
Concentra Group HoldingsâĻ |
STRONG BUY
11 analysts |
$44 | 41 HOLD |
Advanced PACS Option Strategies
Professional options setups generated by AI based on today's PACS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PACS Research Pages
